ODTX

Odyssey Therapeutics, Inc.

Healthcare · Biotechnology

$215.65 sample

+2.96 (+1.39%) 1D

Market cap

$206.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$215.65 +13.05% 3M daily closessample

221.50190.75

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: EVP, Operations
Oct 06SEC8-K filed: material event
Sep 30INSInsider sell: Director
Sep 25INSInsider buy: Chief Executive Officer
Sep 21INSInsider sell: Chief Executive Officer
Sep 16INSInsider sell: Director
Sep 10SECForm 144 filed
Sep 03INSInsider sell: EVP, Operations

Sign up to see the real ODTX record →

Company facts

SEC EDGAR registration

Name: Odyssey Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -29sample, -100 to +100
Reporting currency: USD

Who is positioning in ODTX

sample

Insiders: 18 insider transactions over 90 days, net selling, $403.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 17 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.9B +13.5% y/y

Q4 2024Q3 2026

Inventory$7.1B +10.2% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +12.7% y/y

Q4 2024Q3 2026

Total debt$14.7B +11.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $166.8B -0.6% 3M
Sample peer B: $151.0B +0.1% 3M
Sample peer C: $157.3B +9.1% 3M
Sample peer D: $151.8B +13.3% 3M
Sample peer E: $69.1B +0.1% 3M